Artal Group’s IDEAYA Biosciences IDYA Stock Holding History

Artal Group’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	–	–	141
2020 Q3	$0	Sell	8 -239,296	-100%	-$2.96M	﹤0.01%	147
2020 Q2	$3.4M	Buy	+239,304	New	+$1.89M	0.1%	114

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group's IDYA Position: Q4 2020 in Review

Artal Group sold out of IDEAYA Biosciences (IDYA) in Q4 2020, closing a stake of 8 shares.

Artal Group first reported a position in IDYA in Q2 2020 and held it in 2 quarters. The position peaked at $3.4M in Q2 2020. 82 funds tracked by Wall St. Rank hold IDYA as of Q4 2020.

Artal Group reported no remaining IDEAYA Biosciences position as of Q4 2020 after selling out during the quarter.
Artal Group sold 8 IDEAYA Biosciences shares in Q4 2020.
Artal Group first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 2 quarters.
Artal Group's IDEAYA Biosciences position peaked at $3.4M in Q2 2020.
82 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2020.

Based on Artal Group's 13F filing for Q4 2020, filed 11 Feb 2021.